Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Hackman Jeffrey S. received 1,159 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded May 31, 2026 · Filed Jun 1, 2026
On May 31, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 1,159 Fennec Pharmaceuticals Inc. shares as an award, leaving 62,825 shares. Filed Jun 1, 2026 (Form 4).
- Awarded
- 1,159 shares
- Holding after
- 62,825 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 31, 2026 | Common Shares | Award | 1,159 | 62,825 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Hackman Jeffrey S.
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Hackman Jeffrey S. · Oct 13, 2026
- Form 4 · Hackman Jeffrey S. · Oct 1, 2026
- Form 4 · Hackman Jeffrey S. · Aug 31, 2026
- Form 4 · Hackman Jeffrey S. · Aug 3, 2026
- Form 4 · Hackman Jeffrey S. · Jul 1, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026
- Form 4 · Andrade Robert · Oct 1, 2026